Join LES USA-Canada's Boston Chapter and Nutter for a networking reception and life science panel discussion focusing on the importance of treating IP as a strategic business asset.  Key takeaways include:

• Aligning IP with commercial objectives
• Identifying overlooked IP landmines
• Raising capital and preparing for exit
• Managing IP spend

Speakers:

Jonathan Harris, Partner, Nutter

Todd Brady, CEO, Aldeyra Therapeutics

Romesh Subramanian, President and CEO, Marrow Therapeutics